Novartis Ag
NVS
←Back to Recent Filings
| Filing |
DATE |
FP |
FY |
End Date |
URL |
VIEW |
|
| 6-K |
7/17/2025 |
Q2 |
2025 |
6/30/2025 |
SEC |
view |
|
| 20-F |
2/1/2025 |
Q4 |
2024 |
12/31/2024 |
SEC |
view |
|
| 6-K |
7/18/2024 |
Q2 |
2024 |
6/30/2024 |
SEC |
view |
|
| 20-F |
1/31/2024 |
Q4 |
2023 |
12/31/2023 |
SEC |
view |
|
| 6-K |
7/18/2023 |
Q2 |
2023 |
6/30/2023 |
SEC |
view |
|
| 20-F/A |
5/15/2023 |
Q4 |
2022 |
12/31/2022 |
SEC |
view |
|
| 20-F |
2/1/2023 |
Q4 |
2022 |
12/31/2022 |
SEC |
view |
|
| 6-K |
7/19/2022 |
Q2 |
2022 |
6/30/2022 |
SEC |
view |
|
| 20-F/A |
4/26/2022 |
Q4 |
2021 |
12/31/2021 |
SEC |
view |
|
| 20-F |
2/2/2022 |
Q4 |
2021 |
12/31/2021 |
SEC |
view |
|
| 6-K |
7/21/2021 |
Q2 |
2021 |
6/30/2021 |
SEC |
view |
|
| 20-F |
1/26/2021 |
Q4 |
2020 |
12/31/2020 |
SEC |
view |
|
| 6-K |
7/21/2020 |
Q2 |
2020 |
6/30/2020 |
SEC |
view |
|
| 20-F |
1/29/2020 |
Q4 |
2019 |
12/31/2019 |
SEC |
view |
|
| 6-K |
7/18/2019 |
Q2 |
2019 |
6/30/2019 |
SEC |
view |
|
| 20-F |
1/30/2019 |
Q4 |
2018 |
12/31/2018 |
SEC |
view |
|
| 6-K |
7/18/2018 |
Q2 |
2018 |
6/30/2018 |
SEC |
view |
|
| 6-K |
1/24/2018 |
Q4 |
2017 |
12/31/2017 |
SEC |
view |
|